Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Arrogene, Inc. logo — Innovative cancer treatment technology delivering advanced n...

Arrogene, Inc.

Innovative cancer treatment technology delivering advanced nano agents to target tumors, enhancing patient outcomes and offering personalized care solutions.

Founded 2007 1 employees Series Unknown Total: $7.90M Biotechnology, Health Care

General Information

Company Name Arrogene, Inc.
Founded Year 2007
Founders / Decision Makers
Team member Team member
Employees 1
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Arrogene, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Arrogene, Inc.

Arrogene, Inc. is a biotechnology company founded in 2007 with a focus on developing innovative cancer treatment technologies. The company's slogan "Innovative cancer treatment technology delivering advanced nano agents to target tumors, enhancing patient outcomes and offering personalized care solutions" summarizes their approach. Arrogene's pioneering advancements involve crafting nano agents capable of transporting peptide, protein, and oligonucleotide therapeutics through the blood-brain barrier, providing a specialized approach in nano-medicine. Their technology stands out for effectively delivering a combination of tumor inhibitors or imaging agents, catering to various cancer types. The last notable milestone for Arrogene was a $3.23M Venture Round investment on 08 May 2018. This funding signifies a vote of confidence in the company's potential to make a significant impact in the biotechnology and healthcare industries.

Taxonomy: cancer treatment, nano agents, tumor inhibitors, imaging agents, peptide therapeutics, protein therapeutics, oligonucleotide therapeutics, blood-brain barrier, personalized care solutions, nanomedicine, precision medicine, oncology technology, targeted therapy, patient outcomes

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 08 May 2018
Debt Financing •••••• - 18 Mar 2016
Debt Financing •••••• - 07 Jan 2015
Debt Financing •••••• - 07 Mar 2014
Venture Round •••••• - 12 Jun 2013

View All 7 Funding Rounds

Arrogene, Inc. Alternatives & Competitors

Arrogene, Inc. vs
Shasqi
Shasqi United States

Targeting cancer with click chemistry

Series B
28 employees
Biotechnology, Health Care
Arrogene, Inc. vs
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. United States

Targeted α-Particle Radiotherapy for Cancer

Grant
10 employees
Biotechnology, Health Care
Arrogene, Inc. vs
Imagin Medical
Imagin Medical United States

Establishing a New Standard of Care

Post Ipo Debt
6 employees
Health Care, Pharmaceutical

FAQ About Arrogene, Inc.

Innovative cancer treatment technology delivering advanced nano agents to target tumors, enhancing patient outcomes and offering personalized care solutions.
Arrogene, Inc. was founded in 2007.
Arrogene, Inc. operates in the following industries: Biotechnology, Health Care.
Arrogene, Inc. has approximately 1 employees.
Arrogene, Inc. has completed 7 funding rounds, raising a total of $7.90M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Arrogene, Inc. include Shasqi, Viewpoint Molecular Targeting, Inc., Imagin Medical, Clearity, Silverback Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arrogene, Inc. and Shasqi are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Arrogene, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy